Jeffrey Duchemin
CIK 1585223 · View on SEC EDGAR ↗
First SEC filing: July 2, 2014 · Latest: July 2, 2014
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| April 12, 2019 | HBIO | S 10b5-1 | 400 | $4.65 | $1,860 | 830,888 Direct | -0.05% | Disposed | -83.7% (price as of 2026-08-21) |
| April 11, 2019 | HBIO | S 10b5-1 | 12,425 | $4.51 | $56,037 | 831,288 Direct | -1.47% | Disposed | -83.2% (price as of 2026-08-21) |
| April 10, 2019 | HBIO | S 10b5-1 | 6,332 | $4.50 | $28,494 | 843,713 Direct | -0.74% | Disposed | -83.1% (price as of 2026-08-21) |
| Aug. 9, 2018 | HBIO | S 10b5-1 | 44,500 | $6.41 | $285,245 | 790,742 Direct | -5.33% | Disposed | -88.2% (price as of 2026-08-21) |
| Aug. 8, 2018 | HBIO | S 10b5-1 | 5,500 | $6.35 | $34,925 | 790,742 Direct | -0.69% | Disposed | -88.0% (price as of 2026-08-21) |
| Aug. 7, 2018 | HBIO | S 10b5-1 | 100,000 | $6.07 | $607,000 | 790,742 Direct | -11.23% | Disposed | -87.5% (price as of 2026-08-21) |
| July 11, 2018 | HBIO | S 10b5-1 | 14,205 | $5.22 | $74,150 | 790,742 Direct | -1.76% | Disposed | -85.5% (price as of 2026-08-21) |
| July 10, 2018 | HBIO | S 10b5-1 | 11,600 | $5.38 | $62,408 | 804,947 Direct | -1.42% | Disposed | -85.9% (price as of 2026-08-21) |
| July 9, 2018 | HBIO | S 10b5-1 | 14,195 | $5.41 | $76,795 | 816,547 Direct | -1.71% | Disposed | -86.0% (price as of 2026-08-21) |
| March 9, 2018 | HBIO | S | 7,800 | $4.60 | $35,880 | 641,854 Direct | -1.20% | Disposed | -83.5% (price as of 2026-08-21) |
| March 8, 2018 | HBIO | S | 79,222 | $4.52 | $358,083 | 649,654 Direct | -10.87% | Disposed | -83.2% (price as of 2026-08-21) |
| June 12, 2017 | HBIO | S | 22,000 | $2.66 | $58,520 | 788,984 Direct | -2.71% | Disposed | -71.5% (price as of 2026-08-21) |
| June 12, 2017 | HBIO | P | 22,000 | $2.76 | $60,720 | 810,984 Direct | +2.79% | Acquired | -72.5% (price as of 2026-08-21) |
| Nov. 3, 2016 | HBIO | P | 15,000 | $2.42 | $36,300 | 462,623 Direct | +3.35% | Acquired | -68.6% (price as of 2026-08-21) |
| Dec. 10, 2015 | HBIO | P | 10,000 | $3.37 | $33,700 | 160,210 Direct | +6.66% | Acquired | -77.5% (price as of 2026-08-21) |
| Sept. 2, 2015 | HBIO | P | 2,000 | $4.41 | $8,820 | 150,210 Direct | +1.35% | Acquired | -82.8% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| March 7, 2019 | HBIO | Stock option (right to buy) | Common Stock, par value $0.01 per share (271,139) | $3.79 | March 7, 2029 | 271,139 | Acquired |
| Aug. 9, 2018 | HBIO | Stock option (right to buy) | Common Stock, par value $0.01 per share (394,500) | $4.31 | Nov. 18, 2023 | 44,500 | Disposed |
| Aug. 8, 2018 | HBIO | Stock option (right to buy) | Common Stock, par value $0.01 per share (400,000) | $4.31 | Nov. 18, 2013 | 5,500 | Disposed |
| Aug. 7, 2018 | HBIO | Stock option (right to buy) | Common Stock, par value $0.01 per share (500,000) | $4.31 | Nov. 18, 2023 | 100,000 | Disposed |
| June 4, 2015 | HBIO | Stock option (right to buy) | Common Stock, par value $0.01 per share (130,000) | $5.56 | June 4, 2025 | 130,000 | Acquired |
| May 30, 2014 | HBIO | Stock option (right to buy) | Common Stock, par value $0.01 per share (300,000) | $4.12 | May 30, 2024 | 300,000 | Acquired |
| Nov. 18, 2013 | HBIO | Stock option (right to buy) | Common Stock, par value $0.01 per share (500,000) | $4.31 | Nov. 18, 2023 | 500,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2019 | $305,461 | — | — | — | — | — | — | $1,845,357 |
| 2018 | $551,580 | $367,620 | — | — | — | — | $24,109 | $1,759,305 |
| 2017 | $526,536 | $158,085 | — | — | — | — | $24,109 | $1,531,231 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.